Can’t find a document?
Request Information
CH-Q0007 : Copptech: A Antiviral Biotech
Project Status: Implementation
The project's goal is to provide Covid-19 crisis response financing for sustaining andpromoting Copptech's expansion to improve households and business resilience against Covid-19. Copptech develops and manufactures chemicals based on zinc and copper that neutralize the effect of the Cov-SARS-2 virus in different types of surfaces, such as wood polymers and metals. Its requesting a loan from LIFESS to comply with a drastic increase in demand for its products.
Project Detail
Project Number
CH-Q0007
Approval date
January 10, 2023
Project Country
Chile
Project Sector
PRIVATE FIRMS AND SME DEVELOPMENT
Project Subsector
ENTERPRISE DEVELOPMENT, CLUSTERS AND INNOVATION
Project Type
Equity
Project Lending Type
NSG
Project Modality
Project Facility Type
Project Status
Implementation
Operation Number
EQU/MS-19858-CH
Financial Information
Project Number
CH-Q0007
Project Status
Implementation
IDB Financing
Financing type
EQU
Fund
MIF-Small Enterprise Investment Fund
Reporting currency
USD - United States Dollar
Reporting date
Jun/05/2023
Roles & Responsibilities
Contract signature date
Jan/10/2023
Project Information
Total Cost
USD 1
Country counterpart financing
USD 0
Amount
USD 1
This project doesn't have public documents